Effect of granulocyte colony-stimulating factor on endothelial progenitor cell for coronary artery lesion in Kawasaki disease mice model
- Author:
- No author available
- Journal Title:
- Chinese Journal of Pediatrics
- Issue:
- 10
- DOI:
- 10.3760/cma.j.issn.0578-1310.2012.10.018
- Key Word:
- 川崎病;小鼠;粒细胞集落刺激因子;内皮祖细胞;Kawasaki disease;Mice;Granulocyte colony-stimulating factor;Endothelial progenitor cell
Abstract： Objective Number and function of endothelial progenitor cell (EPC) and coronary artery lesion in Kawasaki disease (KD) model were evaluated to investigate therapeutic efficacy of granulocyte colony-stimulating factor (G-CSF).Method C57BL/6 mice were injected with L.casei cell wall extract (LCWE) ; 48 mice were divided into 3 groups randomly:KD model group; G-CSF treated model group and control group,16 in each.G-CSF was subcutaneously injected from day 5 to day 9 after injection of LCWE.Coronary artery lesion,number of circulating EPC and the function of bone marrow EPC were evaluated.Result In model group,inflammatory infiltration was found around coronary artery at 14 days.The number of circulating EPC was significantly decreased in model group (0.017％ ± 0.008％) compared to control (0.028％ ± 0.007％) (t =2.037,P ＜ 0.05).Disruption of elastin was consistently observed at 56 days.Stimulated by G-CSF,inflammatory infiltration was found around the coronary artery at day 14,while the number of circulating EPC (0.042％ ± 0.015％) was increased significantly compared to models (t =4.629,P ＜0.05).At the day 56,the number of circulating EPC was decreased slightly (0.029％ ±0.012％),but still higher than the model group (t =2.789,P ＜ 0.05),and have no significant difference compared to controls (P ＞ 0.05).Furthermore,there was no elastin disruption in the G-CSF group.In model group,bone marrow EPC's proliferation ability of absorbance (A value) was 0.38 ±0.09 in thiazolyl blue assay,less than controls (0.61 ± 0.14,P ＜ 0.01).Adhesion and migration function were down-regulated compared to controls [(3.1 ± 0.6) cells/HPF and (3.3 ± 0.6) cells/HPF vs.(6.4 ± 1.2)cells/HPF and (6.2 ±0.5) cells/HPF,both P ＜0.01].In the G-CSF treated group,proliferation ability (A 0.58 ±0.10),adhesion [(6.17 ± 1.13) cells/HPF],migration [(6.29 ±0.42) cells/HPF] function were increased significantly compared to the model group (P ＜0.01).Conclusion G-CSF can up-regulate EPC number and function to prevent coronary artery lesion in mice model of KD.
- [1]LIU Jun-feng,DU Zhong-dong,CHEN Zhi,etc.Endothelial progenitor cell down-regulation in a mouse model of Kawasaki disease[J].2012,(3).
- [2]Uehara R,Chihara I,Yanagawa H,etc.Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey.[J].2010,20(4).
- [3]T, Asahara,T, Murohara,A, Sullivan,etc.Isolation of putative progenitor endothelial cells for angiogenesis.[J].1997,275.
- [4]Ming Guo Xu,Li Na Men,Chun Yu Zhao,etc.The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease[J].2010,169(3).
- [5]T J, Lehman,S M, Walker,V, Mahnovski,etc.Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension.[J].1985,28.
- [6]Bolger AF,Pallasch TJ,Taubert KA,etc.Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associa[J].2004,114(6).
- [7]Katsube Y,Ochi M,Ogawa S,etc.Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence.[J].2007,71(5).
- [8]Masuda H,Asahara T,Kearney M,etc.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.[J].2000,97(7).
- [9]Kuroi A,Imanishi T,Suzuki H,etc.Clinical characteristics of patients with kawasaki disease and levels of peripheral endothelial progenitor cells and blood monocyte subpopulations.[J].2010,74(12).
- [10]Wen-Chan, Huang,Li-Min, Huang,I-Shou, Chang,etc.Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006.[J].2009,123(3).
- [11]Chun-ling FAN,Ping-jin GAO,Zai-qian CHE,etc.Therapeutic neovascularization by autologous transplantation with expanded endothelial progenitor cells from peripheral blood into ischemic hind limbs[J].2005,(9).
- [12]Walenta K,Schiegl T,Bohm M,etc.Circulating endothelial progenitor cells and cardiovascular outcomes.[J].2005,353(10).
- [13]Du ZD,Zhao D,Du J,etc.Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004.[J].2007,26(5).
- [14]Graham RM,Muller DW,Kovacic JC.Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease.[J].2007,42(1).